Cross sector

We cross the line

We understand that many technologies do not fit neatly into any one category. Neither do we. Our strong interdisciplinary teams of attorneys have deep cross-sector expertise to provide a tailored offering to our clients who straddle the boundaries of different technology areas. Whether it’s smart devices, AI (in drug discovery, autonomous vehicles, medical imaging, genetic analysis, or other areas), computational chemistry or digital healthcare, we can advise you on the IP issues in relation to every aspect of your technology.

Results-driven

Our teams of attorneys always provide a diverse blend of experience and insight from different practice areas. This ensures that we provide maximum value in relation to your portfolio, by identifying issues that might not be immediately visible. Our clients’ needs are always our top priority, whether that’s advising on freedom to operate for a digital healthcare app or working together on a filing strategy that takes account of worldwide patent prosecution considerations for a software-implemented diagnostic device.

Cutting-edge crossroads: where tech meets everything else

Our intelligence is anything but artificial. With academic backgrounds and experience in bioinformatics, artificial intelligence, and neural networks, we have the right experts to work with you on your most cutting-edge technologies. We stay ahead of the curve, regularly hosting and attending cross-tech IP events and searching out the brightest and best graduates in the newest technology areas to train with us.

Setting a landmark precedent with The State Bar of California, we’re proud to be the first European IP firm to have European attorneys on the ground in San Francisco. This means that we've got our fingers on the pulse of Silicon Valley, one of the world’s burgeoning innovation capitals.

Nick Bassil

Partner

Tim Copsey

Partner

Kristina Cornish

Partner

Gareth Fennell

Partner

Jennifer Harris

Partner

Alexander Korenberg

Partner

Sarah Lau

Partner

Tom Leonard

Partner

Robin Lloyd

Partner

Nick Shipp

Partner (London) and VP (San Francisco)

Covid-19

AI in Drug Repurposing

To solve the greatest challenges, it often makes sense to turn to the most advanced technology. In healthcare, the present challenge has never been greater: how to combat the coronavirus pandemic.

Technology

AI and drug discovery

Once upon a time, drug discovery was limited by the imagination of the scientists involved. But Artificial Intelligence (AI) / Machine Learning (ML) is pushing the old boundaries of drug discovery in exciting ways.

Protecting the everyday through the Digital Revolution

From aeroplanes to hybrid bicycles, kitchen appliances to inhalers, everything these days is undergoing a digital revolution. As aeroplanes become ever more ‘intelligent’, bicycles help cyclists pedal at the slightest slope, kitchen appliances automatically manage multiple jobs and inhalers check whether patients have taken the correct dose, electronic chips have become ubiquitous and the design of corresponding hardware and software is evolving accordingly. Our Engineering, Life Sciences and Chemistry, and Tech attorneys work together to investigate all possible hardware/software synergies, with the goal of ultimately protecting everything that is protectable.

Using artificial intelligence to fight hereditary diseases

Our attorneys nimbly cross sector lines to work on the most advanced technologies, including those designed to analyse genetic data to diagnose hereditary diseases. Our work on AI-powered genetic analysis is now used in almost 1000 hospitals worldwide.

New materials for high-pressure storage of gas

A client produced new nanoporous materials for natural gas transportation. The new compounds were designed for use in pressure vessels to increase the mass of the stored gas at constant pressure or to reduce the storage pressure for a predetermined mass of gas. Our Engineering attorneys worked together with our Life Science and Chemistry attorneys to dissect the new materials and determine their synergies with the high-pressure containment system, resulting in filings across a large number of jurisdictions.

DNA sequencing – not just biochemistry

We work with a client who is developing next generation DNA sequencing technologies. The latest iteration of their technology involves capturing single nucleotides in microdroplets. To work with their team of scientists, which includes biochemists, chemists, engineers, physicists and electronics specialists, it’s critical that we are suitably interdisciplinary. We pride ourselves on building diverse, cross-sector teams to get the most for our clients.

Cookies improve the way our website works. By using this website you are agreeing to our use of cookies. For more information see our cookie policy I accept